P796 Annual prevalence and clinical outcomes of ulcerative colitis with primary sclerosing cholangitis in Korea over the last 10 years
ECCO'20 Vienna
2020
P797 The inexorable increase of biological exposure in paediatric inflammatory bowel disease: a Scottish population-based, longitudinal study 2015–2019
ECCO'20 Vienna
2020
P798 Societal costs attributable to Crohn’s disease and ulcerative colitis within the first 5 years after diagnosis: –a Danish Nationwide Cost-of-Illness Study 2003–2015
ECCO'20 Vienna
2020
P800 Treatment patterns for biologics in ulcerative colitis and Crohn’s disease: A Danish Nationwide Register Study from 2003 to 2015
ECCO'20 Vienna
2020
P801 Treatment patterns of complex perianal fistula in Crohn’s disease in five European countries: the PREFACE study, a retrospective chart review
ECCO'20 Vienna
2020
P802 Probability of vedolizumab response as defined by clinical decision support tool is associated with lower healthcare utilisation in patients with Crohn’s disease
ECCO'20 Vienna
2020
P803 The risk of spine and hip fracture in patients with inflammatory bowel diseases: a nationwide population-based study
ECCO'20 Vienna
2020
P805 Patients with Crohn’s disease treated with ustekinumab vs. vedolizumab in real-world settings
ECCO'20 Vienna
2020
P806 Increasing incidence of microscopic colitis in a population-based cohort study in a French speaking region of Switzerland
ECCO'20 Vienna
2020
P807 UCEIS is associated with PRO2, partial Mayo and SCCAI remission in UC: preliminary results from a prospective study
ECCO'20 Vienna
2020
P808 Prevalence and factors associated with sleep disturbances in inflammatory bowel disease patients compared with normal controls
ECCO'20 Vienna
2020
P809 Increase of tuberculosis due to combination therapy in inflammatory bowel disease: a nationwide population-based study in Korea
ECCO'20 Vienna
2020
P810 Geriatric impairments in older inflammatory bowel disease patients are associated with higher disease burden: results of a multicentre cohort study
ECCO'20 Vienna
2020
P811 A watchful approach for newly diagnosed Crohn’s disease patients with an inflammatory phenotype
ECCO'20 Vienna
2020